benzodiazepines
Managing Lumbar Disc Herniation: Current Treatment Limitations and Economic Burden
This monograph reviews the diagnosis of lumbar disc herniation; available treatment options, including a discussion ...
MARCH 17, 2025

Researcher Highlights How Demographic Data Can Inform LBP Treatment
A new retrospective cohort study uses demographics and clinical characteristics as a starting point for ...
NOVEMBER 8, 2022

COVID Drug Interacts With Some Pain Meds
Clinicians should not avoid prescribing paxlovid for mild to moderate COVID-19, but they should understand the ...
JUNE 13, 2022

Drug Shortages Continue During COVID-19
Last spring, almost every drug class used for mechanical ventilation, from sedatives to vasopressors, was in short ...
OCTOBER 29, 2021

The Risky Combination of Opioids and Benzos: Payor Strategies for Mitigation
With the concurrent use of benzodiazepines and opioids involved in 16% of fatal overdoses, medication management ...
OCTOBER 21, 2021

Lessening of Drug Testing During Pandemic Strengthened Roots of Opioid Crisis
In addition to the millions of lives claimed by the coronavirus during the COVID-19 pandemic, another group of ...
OCTOBER 12, 2021

Nonopioid Multimodal Pain Protocol Shown Effective After Meniscus Surgery
A novel multimodal pain management protocol is effective at providing immediate pain relief for patients undergoing ...
JULY 16, 2021

Opioid-Alternative Pain Meds Present Unique Toxicity Challenges
The ongoing opioid crisis has expanded treatment options for clinicians, but these therapies bring some unique ...
JUNE 16, 2021

The Risky Combination of Opioids and Benzodiazepines: Strategies for Mitigation
A harm reduction initiative has seen modest but encouraging outcomes involving high-risk ...
JUNE 9, 2021

Byfavo Gains DEA Schedule IV Designation
Acacia Pharma Group announced its sedative remimazolam received DEA designation for injection as a Schedule IV ...
NOVEMBER 10, 2020

Amid Chronic Pain Prescribing Surge, FDA Changes Benzodiazepine Labeling to Include Abuse, Addiction Warnings
With benzodiazepine prescribing increasing for approved indications and off-label uses, the FDA is taking action to ...
SEPTEMBER 30, 2020

Opioid Prescribing Patterns Affect Risk for Overdose in Adolescents, Young Adults
Among privately insured patients aged 12 to 21 years with opioid prescriptions, daily opioid dosage, concurrent ...
SEPTEMBER 8, 2020
